Smith & Nephew (SNN) Cash & Current Investments (2009 - 2025)
Smith & Nephew (SNN) reported Cash & Current Investments of $577.0 million for Q4 2025, down 13.36% on a YoY basis from $666.0 million in Q4 2024, and down 18.39% quarter-over-quarter from $707.0 million in Q2 2025.
Smith & Nephew (SNN) Cash & Current Investments (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Cash & Current Investments for 17 years, with the latest figure at $577.0 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Current Investments fell 13.36% year-over-year to $577.0 million; the trailing twelve-month figure through Dec 2025 stood at $577.0 million (down 13.36% YoY), and the FY2025 full-year result was $577.0 million, up 66.28% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $577.0 million, down from $707.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $2.4 billion in Q4 2021, with the low at $329.0 million in Q4 2023.
- Historically, Cash & Current Investments has averaged $811.6 million across 5 years, with a median of $577.0 million in 2025.
- Annual changes were most pronounced in 2021 — Cash & Current Investments soared 769.75% — and 2022, when it plunged 83.76%.
- Smith & Nephew's Cash & Current Investments stood at $2.4 billion in 2021, then sank by 83.76% to $397.0 million in 2022, then retreated by 17.13% to $329.0 million in 2023, then soared by 102.43% to $666.0 million in 2024, then retreated by 13.36% to $577.0 million in 2025.
- The last three Cash & Current Investments figures came in at $577.0 million (Q4 2025), $707.0 million (Q2 2025), and $666.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1.12 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Smith & Nephew | 5.34 Bn | 4.77 Bn | - | 577.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 577.00 Mn |
| Jun 28, 2025 | 707.00 Mn |
| Dec 31, 2024 | 666.00 Mn |
| Jun 29, 2024 | 561.00 Mn |
| Dec 31, 2023 | 329.00 Mn |
| Dec 31, 2022 | 397.00 Mn |
| Dec 31, 2021 | 2.44 Bn |
| Dec 31, 2020 | 281.00 Mn |
| Jun 30, 2020 | 1.42 Bn |
| Dec 31, 2019 | 283.00 Mn |
| Dec 31, 2018 | 370.00 Mn |
| Jun 30, 2018 | 1.26 Bn |
| Dec 31, 2017 | 183.00 Mn |
| Dec 31, 2016 | 86.00 Mn |
| Dec 31, 2015 | 135.00 Mn |
| Jun 30, 2015 | 1.19 Bn |
| Dec 31, 2014 | 61.00 Mn |
| Sep 30, 2014 | 126.00 Mn |
| Mar 31, 2014 | 102.00 Mn |
| Dec 31, 2013 | 169.00 Mn |